EcoDrugPlus

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSDLEG00000016562
Gene Symbol: TRPM8
1 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSDLEG00000014294
Gene Symbol: TRPV1
3 Cross references
134 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSDLEG00000017542
Gene Symbol: TSPO
3 Cross references
122 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSDLEG00000015701
Gene Symbol: TPH1
1 Cross references
257 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSDLEG00000019091
Gene Symbol: TUBA4A
1 Cross references
223 Possible Orthologues:

Tubulin Alpha-1a Chain

Ensembl ID : ENSDLEG00000005525
Gene Symbol: LOC111174050
3 Cross references
250 Possible Orthologues:

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSDLEG00000002366
Gene Symbol: LOC111178265
3 Cross references
116 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSDLEG00000000861
Gene Symbol: TUBB1
3 Cross references
186 Possible Orthologues:

Tubulin Beta 2a Class Iia

Ensembl ID : ENSDLEG00000001358
Gene Symbol: TUBB2A
3 Cross references
223 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSDLEG00000002147
Gene Symbol: TUBB3
1 Cross references
154 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSDLEG00000013810
Gene Symbol: TUBB4A
1 Cross references
89 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSDLEG00000014334
Gene Symbol: TUBB4B
3 Cross references
178 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).